Smorodintsev Research Institute Of Influenza 1

1. Very little influenza in the WHO European Region during the 2020/21 season, weeks40 2020 to 8 2021
2. A New Intranasal Influenza Vector-Based Vaccine TB/FLU-04L Against Tuberculosis: Preclinical Safety Studies
3. Genetic Diversity of SARS-CoV-2 in Kazakhstan from 2020 to 2022
4. Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up
5. Epidemiological characteristics of acute respiratory viral infections and influenza in Kazakhstan during epidemic seasons from 2018 to 2022
6. Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan
1